SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZEB1 | hg19_v2_chr10_+_31608054_31608156 | -0.77 | 8.5e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_7165662 | 93.63 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
chr1_-_209979375 | 51.61 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr1_-_209979465 | 50.25 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr1_-_27286897 | 46.94 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr1_-_153588765 | 46.49 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
chr8_+_95653302 | 41.77 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
chr1_-_153588334 | 41.45 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
chr16_+_68678739 | 41.01 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr16_+_68679193 | 39.94 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr12_-_52911718 | 39.53 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr8_+_120220561 | 39.08 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr17_-_31204124 | 37.70 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
chr19_+_35607166 | 37.70 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr12_-_52914155 | 37.17 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
chr16_+_68678892 | 36.68 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr12_+_7072354 | 36.32 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
chr1_+_183155373 | 35.16 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
chr2_-_56150910 | 34.92 |
ENST00000424836.2
ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr8_+_95653427 | 34.86 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr19_+_35739631 | 34.65 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_-_27339317 | 34.63 |
ENST00000289166.5
|
FAM46B
|
family with sequence similarity 46, member B |
chr19_+_35606777 | 34.18 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr8_+_95653373 | 33.03 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr2_-_166651152 | 32.94 |
ENST00000431484.1
ENST00000412248.1 |
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr1_-_153363452 | 32.90 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr19_+_35606692 | 32.09 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr11_+_44587141 | 31.92 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
chr2_-_166651191 | 31.68 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr12_-_50677255 | 31.08 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
chr11_+_44587206 | 30.54 |
ENST00000525210.1
ENST00000527737.1 ENST00000524704.1 |
CD82
|
CD82 molecule |
chr1_-_59043166 | 30.45 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr16_-_4987065 | 30.42 |
ENST00000590782.2
ENST00000345988.2 |
PPL
|
periplakin |
chr8_+_102504651 | 30.25 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr6_+_41604747 | 30.11 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
chr15_+_41136586 | 29.15 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr17_-_39684550 | 28.52 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr14_-_61747949 | 28.33 |
ENST00000355702.2
|
TMEM30B
|
transmembrane protein 30B |
chr17_-_39743139 | 27.11 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
chr14_+_21510385 | 26.48 |
ENST00000298690.4
|
RNASE7
|
ribonuclease, RNase A family, 7 |
chr1_-_201368653 | 26.25 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr3_+_50192833 | 25.89 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr2_-_56150184 | 25.66 |
ENST00000394554.1
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr1_-_201368707 | 25.35 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr6_+_54711533 | 25.34 |
ENST00000306858.7
|
FAM83B
|
family with sequence similarity 83, member B |
chr19_+_35739597 | 25.31 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr14_-_75422280 | 25.24 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
chr19_+_39279838 | 24.01 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr1_+_26503894 | 23.99 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
chr16_+_68771128 | 23.84 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr16_-_68269971 | 23.72 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chr15_+_41136734 | 23.67 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr18_+_61143994 | 23.54 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr8_-_49833978 | 23.08 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr8_+_102504979 | 23.06 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr1_+_153330322 | 22.84 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr11_+_94439591 | 22.79 |
ENST00000299004.9
|
AMOTL1
|
angiomotin like 1 |
chr20_+_44098346 | 22.50 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr22_+_40390930 | 22.47 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
chr19_-_42947121 | 22.46 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr20_+_44098385 | 22.19 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr11_-_118134997 | 21.91 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
chr14_-_24729251 | 21.51 |
ENST00000559136.1
|
TGM1
|
transglutaminase 1 |
chr19_+_35739782 | 21.46 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_-_161059380 | 21.38 |
ENST00000368012.3
|
PVRL4
|
poliovirus receptor-related 4 |
chr1_+_145439306 | 21.28 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
chr11_-_118135160 | 21.27 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero-like 2 |
chr12_-_48298785 | 21.17 |
ENST00000550325.1
ENST00000546653.1 ENST00000549336.1 ENST00000535672.1 ENST00000229022.3 ENST00000548664.1 |
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor |
chr1_+_32042131 | 21.14 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr16_-_2908155 | 20.95 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chr5_-_136834242 | 20.83 |
ENST00000282223.7
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chr4_-_74486217 | 20.79 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr11_+_18287801 | 20.67 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr1_+_60280458 | 20.61 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr19_-_12886327 | 20.60 |
ENST00000397668.3
ENST00000587178.1 ENST00000264827.5 |
HOOK2
|
hook microtubule-tethering protein 2 |
chr11_-_64612041 | 20.52 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr11_+_65554493 | 20.50 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chr19_-_51471381 | 20.40 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr1_+_32042105 | 20.26 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr15_+_41136216 | 20.22 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr1_+_36772691 | 20.11 |
ENST00000312808.4
ENST00000505871.1 |
SH3D21
|
SH3 domain containing 21 |
chr12_-_6484376 | 20.01 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr4_-_77819002 | 19.89 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
chr1_-_95007193 | 19.88 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr19_+_35739280 | 19.54 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr11_+_34642656 | 19.40 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr1_-_159915386 | 19.25 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
chr14_-_61748550 | 19.14 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
chr19_+_35739897 | 19.11 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_-_95285764 | 19.08 |
ENST00000414374.1
ENST00000421997.1 ENST00000418366.2 ENST00000452922.1 |
LINC01057
|
long intergenic non-protein coding RNA 1057 |
chrX_-_48328631 | 19.07 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr12_-_6484715 | 18.97 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr19_-_12912657 | 18.94 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
chr2_+_234104079 | 18.81 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr6_+_41606176 | 18.78 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr8_+_144816303 | 18.77 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr6_-_10419871 | 18.64 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr2_+_113885138 | 18.59 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr18_+_61144160 | 18.58 |
ENST00000489441.1
ENST00000424602.1 |
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr11_+_18287721 | 18.58 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr19_+_6464243 | 18.49 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
chr2_+_210288760 | 18.40 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr22_+_45148432 | 18.39 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
chr6_+_30851205 | 18.15 |
ENST00000515881.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr7_-_143991230 | 18.10 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr9_-_21994597 | 18.01 |
ENST00000579755.1
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr19_-_12912601 | 17.96 |
ENST00000334482.5
|
PRDX2
|
peroxiredoxin 2 |
chr19_-_5851442 | 17.86 |
ENST00000458379.2
ENST00000589714.1 ENST00000589918.1 ENST00000303225.6 ENST00000589620.1 |
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) |
chr1_+_156030937 | 17.69 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
chr11_+_71846764 | 17.28 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
chr16_+_71660079 | 17.17 |
ENST00000565261.1
ENST00000268485.3 ENST00000299952.4 |
MARVELD3
|
MARVEL domain containing 3 |
chr1_+_36771946 | 17.07 |
ENST00000373139.2
ENST00000453908.2 ENST00000426732.2 |
SH3D21
|
SH3 domain containing 21 |
chr6_+_7541808 | 16.96 |
ENST00000379802.3
|
DSP
|
desmoplakin |
chr11_-_18270182 | 16.91 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
chr17_-_38657849 | 16.80 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
chrX_-_48328551 | 16.73 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr17_-_39674668 | 16.65 |
ENST00000393981.3
|
KRT15
|
keratin 15 |
chr1_-_40367668 | 16.64 |
ENST00000397332.2
ENST00000429311.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
chr19_-_54676846 | 16.59 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
chr1_-_207206092 | 16.55 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
chr19_-_51472222 | 16.46 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr7_-_143892748 | 16.41 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr6_+_7541845 | 16.34 |
ENST00000418664.2
|
DSP
|
desmoplakin |
chr19_-_54676884 | 16.27 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
chr19_+_45281118 | 16.19 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr1_+_62208091 | 16.14 |
ENST00000316485.6
ENST00000371158.2 |
INADL
|
InaD-like (Drosophila) |
chr20_-_1309809 | 16.12 |
ENST00000360779.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
chr3_-_48594248 | 16.09 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr3_+_40428647 | 16.06 |
ENST00000301825.3
ENST00000439533.1 ENST00000456402.1 |
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3 |
chr9_-_21994344 | 16.02 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chrX_-_100914781 | 15.96 |
ENST00000431597.1
ENST00000458024.1 ENST00000413506.1 ENST00000440675.1 ENST00000328766.5 ENST00000356824.4 |
ARMCX2
|
armadillo repeat containing, X-linked 2 |
chr4_-_74486109 | 15.86 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr10_-_5660118 | 15.82 |
ENST00000427341.1
|
RP11-336A10.4
|
RP11-336A10.4 |
chr17_-_74639886 | 15.76 |
ENST00000156626.7
|
ST6GALNAC1
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
chr11_+_118401899 | 15.75 |
ENST00000528373.1
ENST00000544878.1 ENST00000354284.4 ENST00000533137.1 ENST00000532762.1 ENST00000526973.1 ENST00000354064.7 ENST00000533102.1 ENST00000313236.5 ENST00000527267.1 ENST00000524725.1 ENST00000533689.1 |
TMEM25
|
transmembrane protein 25 |
chr1_+_35220613 | 15.71 |
ENST00000338513.1
|
GJB5
|
gap junction protein, beta 5, 31.1kDa |
chr19_-_10697895 | 15.67 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
chr14_-_24732403 | 15.56 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
chr2_+_219745020 | 15.42 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr7_+_144052381 | 15.34 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr11_-_441964 | 15.26 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr19_-_51472031 | 15.25 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr6_+_44095263 | 15.24 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
chr19_-_36001113 | 15.14 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr5_+_148206156 | 15.04 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr5_+_68711209 | 14.97 |
ENST00000512803.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr1_-_43751230 | 14.90 |
ENST00000523677.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr9_-_21975088 | 14.89 |
ENST00000304494.5
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr1_-_55266926 | 14.78 |
ENST00000371276.4
|
TTC22
|
tetratricopeptide repeat domain 22 |
chr5_-_136834263 | 14.77 |
ENST00000505690.1
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chr19_+_42212526 | 14.60 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr19_-_36001286 | 14.56 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
chr14_-_24732368 | 14.52 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
chr16_+_82660560 | 14.45 |
ENST00000268613.10
ENST00000565636.1 ENST00000431540.3 ENST00000428848.3 |
CDH13
|
cadherin 13 |
chr17_-_6459802 | 14.33 |
ENST00000262483.8
|
PITPNM3
|
PITPNM family member 3 |
chr19_-_11689752 | 14.25 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr12_-_33049690 | 14.22 |
ENST00000070846.6
ENST00000340811.4 |
PKP2
|
plakophilin 2 |
chr15_+_94774767 | 14.15 |
ENST00000543482.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
chr17_+_1665253 | 14.15 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr4_-_74486347 | 14.10 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr22_-_44258360 | 14.08 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr3_-_45187843 | 14.07 |
ENST00000296129.1
ENST00000425231.2 |
CDCP1
|
CUB domain containing protein 1 |
chr5_-_149792295 | 14.02 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr6_-_42110342 | 13.95 |
ENST00000356542.5
|
C6orf132
|
chromosome 6 open reading frame 132 |
chr11_+_71846748 | 13.94 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
chr8_+_27183033 | 13.92 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr21_-_42879909 | 13.66 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
chr11_+_65779283 | 13.66 |
ENST00000312134.2
|
CST6
|
cystatin E/M |
chr15_+_41136369 | 13.63 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr18_+_29078131 | 13.61 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
chr16_-_28550320 | 13.55 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr9_-_117880477 | 13.50 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr5_+_68711023 | 13.44 |
ENST00000515844.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr8_-_143867946 | 13.42 |
ENST00000301263.4
|
LY6D
|
lymphocyte antigen 6 complex, locus D |
chr1_+_31885963 | 13.42 |
ENST00000373709.3
|
SERINC2
|
serine incorporator 2 |
chr17_-_6459768 | 13.25 |
ENST00000421306.3
|
PITPNM3
|
PITPNM family member 3 |
chr19_-_12912688 | 13.16 |
ENST00000435703.1
|
PRDX2
|
peroxiredoxin 2 |
chr9_-_22009297 | 13.01 |
ENST00000276925.6
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
chr1_-_161008697 | 13.01 |
ENST00000318289.10
ENST00000368023.3 ENST00000368024.1 ENST00000423014.2 |
TSTD1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr1_+_150254936 | 13.00 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
chr22_+_31608219 | 12.96 |
ENST00000406516.1
ENST00000444929.2 ENST00000331728.4 |
LIMK2
|
LIM domain kinase 2 |
chrX_+_102469997 | 12.95 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
chr17_+_29815113 | 12.95 |
ENST00000583755.1
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
chr1_+_209878182 | 12.94 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr4_+_152330390 | 12.93 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
chr11_+_59522900 | 12.91 |
ENST00000529177.1
|
STX3
|
syntaxin 3 |
chr19_-_51523275 | 12.88 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr8_-_127570603 | 12.84 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
chr11_+_32851487 | 12.84 |
ENST00000257836.3
|
PRRG4
|
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
chr1_+_89829610 | 12.78 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr7_+_18535893 | 12.70 |
ENST00000432645.2
ENST00000441542.2 |
HDAC9
|
histone deacetylase 9 |
chr6_+_36097992 | 12.66 |
ENST00000211287.4
|
MAPK13
|
mitogen-activated protein kinase 13 |
chr6_+_30850697 | 12.58 |
ENST00000509639.1
ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr10_-_50747064 | 12.53 |
ENST00000355832.5
ENST00000603152.1 ENST00000447839.2 |
ERCC6
PGBD3
ERCC6-PGBD3
|
excision repair cross-complementing rodent repair deficiency, complementation group 6 piggyBac transposable element derived 3 ERCC6-PGBD3 readthrough |
chr2_+_14772810 | 12.53 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
chr8_-_124553437 | 12.51 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr1_-_111746966 | 12.48 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr6_+_44095347 | 12.47 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
chr3_-_69435224 | 12.46 |
ENST00000398540.3
|
FRMD4B
|
FERM domain containing 4B |
chr1_-_155162658 | 12.46 |
ENST00000368389.2
ENST00000368396.4 ENST00000343256.5 ENST00000342482.4 ENST00000368398.3 ENST00000368390.3 ENST00000337604.5 ENST00000368392.3 ENST00000438413.1 ENST00000368393.3 ENST00000457295.2 ENST00000338684.5 ENST00000368395.1 |
MUC1
|
mucin 1, cell surface associated |
chr6_+_32937083 | 12.30 |
ENST00000456339.1
|
BRD2
|
bromodomain containing 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.4 | 117.6 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
20.0 | 120.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
19.9 | 19.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
9.6 | 115.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
9.6 | 28.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
9.3 | 9.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
8.7 | 61.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
8.2 | 65.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
8.1 | 24.2 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
8.0 | 8.0 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
7.6 | 22.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
7.6 | 22.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
7.0 | 27.9 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
6.7 | 60.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
6.2 | 62.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
6.0 | 223.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.0 | 36.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
6.0 | 18.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
5.9 | 17.7 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
5.6 | 39.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.5 | 44.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.5 | 11.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
5.4 | 65.3 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
5.4 | 5.4 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
5.3 | 15.8 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
5.2 | 20.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
5.1 | 15.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
5.0 | 35.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
5.0 | 15.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
4.9 | 14.6 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
4.6 | 4.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
4.5 | 112.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
4.4 | 4.4 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
4.4 | 31.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
4.3 | 17.3 | GO:0042223 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
4.3 | 17.3 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
4.3 | 25.7 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
4.3 | 25.5 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
4.1 | 57.6 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
4.1 | 73.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
4.0 | 20.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
4.0 | 12.0 | GO:2000452 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
3.9 | 7.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
3.8 | 15.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
3.8 | 18.8 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
3.7 | 7.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
3.7 | 18.6 | GO:0003409 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
3.7 | 11.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
3.6 | 7.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
3.6 | 10.7 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
3.5 | 24.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
3.5 | 17.7 | GO:0015688 | response to mycotoxin(GO:0010046) iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.5 | 21.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
3.5 | 72.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
3.3 | 10.0 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
3.3 | 33.2 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
3.2 | 19.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
3.1 | 27.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
3.1 | 74.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
3.1 | 18.5 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
3.1 | 162.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
3.0 | 27.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.0 | 12.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.0 | 9.0 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
2.9 | 43.8 | GO:0051665 | membrane raft localization(GO:0051665) |
2.9 | 14.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.8 | 14.0 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.8 | 16.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
2.7 | 30.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.7 | 8.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
2.7 | 2.7 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
2.7 | 98.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
2.6 | 7.9 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
2.6 | 10.5 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
2.6 | 52.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
2.6 | 7.8 | GO:0042938 | dipeptide transport(GO:0042938) |
2.6 | 10.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.4 | 4.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.4 | 4.8 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
2.4 | 7.2 | GO:0048627 | myoblast development(GO:0048627) |
2.4 | 23.8 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.4 | 7.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
2.3 | 18.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.2 | 38.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
2.2 | 2.2 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
2.2 | 40.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
2.2 | 15.3 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
2.2 | 6.5 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
2.2 | 4.3 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
2.1 | 10.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.1 | 10.6 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
2.1 | 31.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.1 | 31.2 | GO:0015884 | folic acid transport(GO:0015884) |
2.0 | 16.2 | GO:0007296 | vitellogenesis(GO:0007296) |
2.0 | 14.1 | GO:0051697 | protein delipidation(GO:0051697) |
2.0 | 15.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.9 | 3.9 | GO:0035627 | ceramide transport(GO:0035627) |
1.9 | 7.5 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
1.9 | 5.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.8 | 5.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.8 | 12.9 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.8 | 5.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.8 | 27.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
1.8 | 23.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.8 | 14.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
1.8 | 9.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
1.8 | 32.1 | GO:0015816 | glycine transport(GO:0015816) |
1.8 | 3.6 | GO:0032796 | uropod organization(GO:0032796) protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
1.8 | 3.5 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
1.8 | 21.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.7 | 7.0 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
1.7 | 20.6 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
1.7 | 15.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.7 | 5.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.6 | 4.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.6 | 8.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.6 | 11.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
1.6 | 14.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.6 | 11.2 | GO:0030035 | microspike assembly(GO:0030035) |
1.6 | 6.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
1.6 | 8.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.6 | 17.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.6 | 4.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.6 | 4.7 | GO:0030070 | insulin processing(GO:0030070) |
1.6 | 6.3 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
1.6 | 3.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
1.6 | 20.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.6 | 12.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.6 | 10.9 | GO:0007172 | signal complex assembly(GO:0007172) |
1.6 | 9.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
1.5 | 30.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.5 | 1.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
1.5 | 16.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.5 | 10.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.5 | 6.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
1.5 | 6.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.5 | 13.5 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.5 | 6.0 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
1.5 | 4.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
1.5 | 5.9 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.5 | 13.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.5 | 10.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.4 | 50.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.4 | 12.6 | GO:0046836 | glycolipid transport(GO:0046836) |
1.4 | 7.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.4 | 12.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 27.6 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
1.4 | 15.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.4 | 5.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.4 | 5.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
1.4 | 10.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
1.3 | 8.1 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
1.3 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.3 | 4.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
1.3 | 6.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
1.3 | 6.6 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
1.3 | 5.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.3 | 1.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.3 | 6.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.3 | 14.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.3 | 33.7 | GO:0051639 | actin filament network formation(GO:0051639) |
1.3 | 6.5 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
1.3 | 3.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.3 | 114.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.3 | 5.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.3 | 5.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
1.3 | 12.6 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.3 | 2.5 | GO:0042704 | uterine wall breakdown(GO:0042704) |
1.2 | 5.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.2 | 3.7 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
1.2 | 17.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.2 | 7.4 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.2 | 7.4 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
1.2 | 3.7 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
1.2 | 4.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.2 | 20.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.2 | 3.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.2 | 6.0 | GO:0035900 | response to isolation stress(GO:0035900) |
1.2 | 4.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.2 | 19.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.2 | 32.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.2 | 38.0 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
1.2 | 4.7 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development involved in symbiotic interaction(GO:0044111) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
1.2 | 3.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.2 | 5.9 | GO:0016129 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
1.2 | 9.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.2 | 2.3 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
1.2 | 4.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.2 | 9.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.2 | 8.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
1.2 | 4.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.2 | 9.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.2 | 10.4 | GO:0015677 | copper ion import(GO:0015677) |
1.2 | 5.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
1.2 | 17.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
1.1 | 8.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.1 | 3.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.1 | 5.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.1 | 12.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
1.1 | 10.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.1 | 32.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.1 | 1.1 | GO:0090288 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) negative regulation of cellular response to growth factor stimulus(GO:0090288) |
1.1 | 7.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.1 | 6.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.1 | 4.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
1.1 | 8.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.1 | 11.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.0 | 3.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 14.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 12.3 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
1.0 | 4.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 2.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.0 | 2.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.0 | 12.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
1.0 | 3.9 | GO:0099563 | modification of synaptic structure(GO:0099563) |
1.0 | 11.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
1.0 | 17.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.0 | 3.9 | GO:0061550 | cranial ganglion development(GO:0061550) |
1.0 | 2.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.0 | 16.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.0 | 2.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 2.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.9 | 2.8 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.9 | 9.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.9 | 15.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.9 | 7.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.9 | 7.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.9 | 5.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.9 | 6.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.9 | 11.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.9 | 11.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.9 | 44.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.9 | 69.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.9 | 10.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.9 | 13.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.9 | 2.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.9 | 2.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 5.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 15.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.9 | 7.1 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 13.1 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 5.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.9 | 6.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.9 | 0.9 | GO:1904469 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.9 | 2.6 | GO:0021503 | neural fold bending(GO:0021503) |
0.9 | 18.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.9 | 6.0 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.9 | 8.5 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 4.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.8 | 3.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 2.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.8 | 18.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.8 | 3.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.8 | 2.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.8 | 3.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.8 | 1.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.8 | 4.1 | GO:0002415 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.8 | 6.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 6.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.8 | 19.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.8 | 5.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.8 | 3.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 | 4.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.8 | 3.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.8 | 4.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.8 | 23.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.8 | 5.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.8 | 7.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 1.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 2.4 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.8 | 12.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.8 | 169.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.8 | 4.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 13.2 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.8 | 2.3 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.8 | 6.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.8 | 3.8 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.8 | 2.3 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.8 | 6.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.8 | 2.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.8 | 2.3 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
0.8 | 2.3 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.8 | 6.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.7 | 2.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.7 | 40.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.7 | 7.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 2.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 22.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.7 | 3.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 7.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.7 | 3.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 4.4 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.7 | 18.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.7 | 10.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.7 | 3.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.7 | 8.6 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 8.6 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.7 | 12.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 11.4 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 3.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.7 | 1.4 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.7 | 2.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.7 | 4.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.7 | 38.3 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.7 | 1.4 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 2.7 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.7 | 5.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 5.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.7 | 17.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.7 | 5.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 2.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.7 | 2.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.7 | 3.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.7 | 3.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.6 | 2.6 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.6 | 5.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 15.3 | GO:0060004 | reflex(GO:0060004) |
0.6 | 2.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 5.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 1.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.6 | 4.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.6 | 2.5 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.6 | 5.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.6 | 5.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.2 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.6 | 12.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 3.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 0.6 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.6 | 3.1 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.6 | 3.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.6 | 2.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.6 | 1.2 | GO:0042335 | cuticle development(GO:0042335) |
0.6 | 2.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 1.8 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.6 | 9.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 1.8 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.6 | 3.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.6 | 3.6 | GO:0030073 | insulin secretion(GO:0030073) |
0.6 | 5.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 1.8 | GO:0031247 | actin rod assembly(GO:0031247) |
0.6 | 1.8 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.6 | 2.9 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.6 | 4.7 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.6 | 10.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.6 | 7.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 8.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 2.3 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.6 | 12.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.6 | 2.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 4.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 5.0 | GO:0032606 | regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
0.6 | 2.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.6 | 0.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.6 | 19.9 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.6 | 2.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.5 | 1.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 6.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 1.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.5 | 1.6 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.5 | 2.7 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.5 | 3.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.5 | 14.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.5 | 3.3 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 2.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 5.9 | GO:0043297 | apical junction assembly(GO:0043297) |
0.5 | 5.4 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.5 | 8.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 3.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 5.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.5 | 4.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.5 | 5.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.5 | 7.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.5 | 4.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.5 | 7.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.5 | 10.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 5.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 6.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.5 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 7.6 | GO:0072189 | ureter development(GO:0072189) |
0.5 | 0.5 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
0.5 | 2.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 2.5 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.5 | 5.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 14.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.5 | 2.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.5 | 0.5 | GO:0045218 | cell-cell junction maintenance(GO:0045217) zonula adherens maintenance(GO:0045218) |
0.5 | 4.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 2.5 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 2.5 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.5 | 1.0 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.5 | 47.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 1.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.5 | 3.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 5.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.5 | 1.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.5 | 2.9 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.5 | 3.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 0.9 | GO:0048864 | stem cell development(GO:0048864) |
0.5 | 1.4 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.5 | 1.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 | 1.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.5 | 17.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 4.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.5 | 2.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.4 | 5.8 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.4 | 11.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.4 | 0.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 4.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 27.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.4 | 0.9 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.4 | 4.4 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.4 | 9.2 | GO:0098743 | cell aggregation(GO:0098743) |
0.4 | 1.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 4.4 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.4 | 4.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.4 | 0.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.4 | 2.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.4 | 0.9 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.4 | 8.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 1.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.4 | 3.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.4 | 7.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 0.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 4.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 1.2 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.4 | 4.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 1.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 3.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 1.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 4.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 2.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 4.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 3.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 4.8 | GO:0099612 | protein localization to axon(GO:0099612) |
0.4 | 7.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 2.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 6.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 3.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.4 | 4.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.4 | 3.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 1.9 | GO:0048749 | compound eye development(GO:0048749) |
0.4 | 1.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 6.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 13.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.4 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 2.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 13.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 1.5 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.4 | 5.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 3.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.4 | 11.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 6.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 4.4 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.4 | 3.6 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.4 | 2.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.4 | 1.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 14.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.4 | 12.3 | GO:0006396 | RNA processing(GO:0006396) |
0.4 | 32.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 2.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 2.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 6.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 3.8 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 9.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 17.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 2.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.0 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 1.7 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.3 | 3.7 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 5.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 5.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 4.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 15.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 2.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.0 | GO:0070781 | response to biotin(GO:0070781) |
0.3 | 1.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 15.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 5.5 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 9.7 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.3 | 1.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 4.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 1.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 8.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 3.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 8.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 4.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.3 | 21.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 2.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 0.6 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.3 | 0.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 0.9 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.3 | 1.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 1.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 2.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.3 | 11.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.3 | 1.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 4.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 0.9 | GO:0021551 | central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
0.3 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 1.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 8.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 4.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 1.2 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.3 | 5.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 2.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.3 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 2.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.3 | 0.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.3 | 2.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.3 | 4.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 0.9 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 3.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 5.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 3.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 2.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 7.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 2.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 11.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 4.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 1.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 1.6 | GO:1901909 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.3 | 2.1 | GO:0046959 | habituation(GO:0046959) |
0.3 | 27.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 2.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 4.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 2.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.3 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.0 | GO:0010446 | response to alkaline pH(GO:0010446) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.3 | 1.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.0 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.3 | 8.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 5.3 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.3 | 2.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 9.5 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.2 | 1.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 1.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 2.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 5.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
0.2 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 2.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 1.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 1.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 4.0 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 1.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 2.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 5.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 2.5 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.9 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 1.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 2.5 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.2 | 2.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 1.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 26.0 | GO:0070268 | cornification(GO:0070268) |
0.2 | 5.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 2.2 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.2 | 2.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 39.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 2.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.0 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 46.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.2 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 5.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 4.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.8 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) sulfur amino acid biosynthetic process(GO:0000097) |
0.2 | 0.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 5.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.2 | 1.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 2.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.2 | 0.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 2.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 1.6 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.2 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 1.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.0 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.2 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 7.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.2 | 1.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 3.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 | 4.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 4.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.5 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 2.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 2.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 3.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.4 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 2.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 3.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 8.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 6.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 6.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 3.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.8 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.2 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 5.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.2 | 2.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 12.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 1.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 3.2 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 1.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 9.1 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 2.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 4.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 3.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.9 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 4.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 2.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 4.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 1.0 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 5.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 0.9 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.7 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 5.0 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 5.1 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.6 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.1 | 4.5 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.1 | 2.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.7 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 0.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 1.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 2.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 2.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 16.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.8 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 3.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 11.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 2.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 2.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 1.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 2.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 1.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 1.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.9 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 1.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 5.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 1.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 3.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 1.2 | GO:0021510 | spinal cord development(GO:0021510) |
0.1 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 2.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 2.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 3.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 2.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.3 | GO:0045764 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) positive regulation of cellular amino acid metabolic process(GO:0045764) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) comma-shaped body morphogenesis(GO:0072049) metanephric comma-shaped body morphogenesis(GO:0072278) metanephric nephron tubule formation(GO:0072289) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.5 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.1 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 2.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 11.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 2.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 15.9 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.9 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 4.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 3.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 2.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.2 | GO:0045554 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.1 | 0.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.1 | 0.3 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 0.2 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.1 | 3.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 3.8 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.3 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.1 | 2.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 3.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.3 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.1 | 4.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.1 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 4.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.6 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 1.6 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.5 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 1.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 3.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 1.3 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.0 | 1.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 1.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.6 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.0 | 0.2 | GO:0051251 | positive regulation of cell activation(GO:0050867) positive regulation of lymphocyte activation(GO:0051251) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 1.0 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.4 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.4 | GO:0071377 | response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 2.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0072139 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) lung ciliated cell differentiation(GO:0061141) glomerular parietal epithelial cell differentiation(GO:0072139) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.8 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.4 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.3 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 1.0 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.3 | GO:0009791 | post-embryonic development(GO:0009791) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.5 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0002818 | intracellular defense response(GO:0002818) |
0.0 | 0.2 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 1.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.0 | 168.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
8.6 | 34.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
7.3 | 29.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
5.9 | 23.8 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
5.4 | 65.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
5.1 | 40.5 | GO:0070695 | FHF complex(GO:0070695) |
4.9 | 19.7 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
3.7 | 15.0 | GO:0043194 | axon initial segment(GO:0043194) |
3.0 | 18.2 | GO:0034678 | smooth muscle contractile fiber(GO:0030485) integrin alpha8-beta1 complex(GO:0034678) |
3.0 | 27.1 | GO:0035976 | AP1 complex(GO:0035976) |
3.0 | 212.8 | GO:0001533 | cornified envelope(GO:0001533) |
2.9 | 23.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
2.8 | 19.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.6 | 5.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
2.6 | 94.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.3 | 47.9 | GO:0043203 | axon hillock(GO:0043203) |
2.2 | 17.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
2.2 | 48.9 | GO:0034706 | sodium channel complex(GO:0034706) |
2.1 | 19.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
2.1 | 14.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.1 | 83.9 | GO:0033268 | node of Ranvier(GO:0033268) |
2.0 | 8.1 | GO:0097443 | sorting endosome(GO:0097443) |
2.0 | 66.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
2.0 | 9.9 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
2.0 | 11.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.9 | 7.7 | GO:1990742 | microvesicle(GO:1990742) |
1.9 | 9.6 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
1.9 | 63.1 | GO:0097440 | apical dendrite(GO:0097440) |
1.9 | 7.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.8 | 7.4 | GO:0045179 | apical cortex(GO:0045179) |
1.8 | 9.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.8 | 39.1 | GO:0030056 | hemidesmosome(GO:0030056) |
1.8 | 31.6 | GO:0016342 | catenin complex(GO:0016342) |
1.7 | 5.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
1.7 | 19.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.7 | 1.7 | GO:0030662 | coated vesicle membrane(GO:0030662) |
1.6 | 4.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
1.6 | 55.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.6 | 4.8 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
1.5 | 19.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.5 | 24.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.5 | 4.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
1.4 | 109.0 | GO:0045095 | keratin filament(GO:0045095) |
1.3 | 5.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.3 | 11.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.3 | 3.8 | GO:0008623 | CHRAC(GO:0008623) |
1.3 | 7.5 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 23.8 | GO:0045180 | basal cortex(GO:0045180) |
1.2 | 3.7 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
1.2 | 4.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.2 | 3.5 | GO:0097444 | spine apparatus(GO:0097444) |
1.1 | 4.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.1 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.1 | 17.1 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 6.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.0 | 9.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.0 | 3.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.0 | 5.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 31.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.0 | 2.9 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.9 | 6.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.9 | 6.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.9 | 28.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.9 | 2.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.9 | 10.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 0.9 | GO:0000791 | euchromatin(GO:0000791) |
0.9 | 2.7 | GO:0000806 | Y chromosome(GO:0000806) |
0.9 | 2.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.9 | 17.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 139.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.9 | 22.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 116.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.8 | 11.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 6.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.8 | 1.7 | GO:0008091 | spectrin(GO:0008091) |
0.8 | 30.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 4.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.8 | 13.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.8 | 14.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 83.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.8 | 8.0 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 7.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.8 | 18.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 2.3 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.8 | 6.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.7 | 5.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.8 | GO:0055087 | Ski complex(GO:0055087) |
0.7 | 3.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.7 | 2.8 | GO:0070985 | TFIIK complex(GO:0070985) |
0.7 | 2.7 | GO:1990745 | EARP complex(GO:1990745) |
0.7 | 7.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 4.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 6.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 5.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 4.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 3.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.6 | 8.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 108.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.6 | 10.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 4.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.6 | 14.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 18.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 84.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 7.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 35.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.6 | 2.4 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.6 | 3.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 21.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 5.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.5 | 9.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 1.6 | GO:0033011 | perinuclear theca(GO:0033011) |
0.5 | 3.3 | GO:0031310 | intrinsic component of endosome membrane(GO:0031302) intrinsic component of vacuolar membrane(GO:0031310) |
0.5 | 14.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 2.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.5 | 5.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 32.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 20.6 | GO:0099738 | cell cortex region(GO:0099738) |
0.5 | 12.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 1.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.5 | 7.2 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 3.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 2.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 6.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 0.9 | GO:0048500 | signal recognition particle(GO:0048500) |
0.5 | 1.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.4 | 14.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 2.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 4.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 4.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 37.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.4 | 3.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 5.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 9.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 13.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 26.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.4 | 53.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.4 | 31.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 2.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 19.4 | GO:0002102 | podosome(GO:0002102) |
0.4 | 39.2 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 37.8 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 6.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 23.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 2.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.3 | 9.0 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 0.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.3 | 58.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 13.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 1.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.3 | 44.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 5.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 3.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 7.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 8.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 3.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 5.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 25.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.3 | 14.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.3 | 4.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 4.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.0 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 1.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 2.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.3 | 4.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 8.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 3.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 9.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 19.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 10.0 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 27.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.3 | 7.3 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 19.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 2.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 3.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 2.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 5.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.0 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 2.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 43.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 2.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 3.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.2 | 34.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 25.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 28.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 8.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 209.5 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 1.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 5.8 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 1.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 3.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 3.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 5.1 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.5 | GO:0042025 | host cell nucleus(GO:0042025) |
0.2 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 2.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 9.3 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 6.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 7.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 594.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 5.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 2.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.7 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 15.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 16.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 16.9 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) symmetric synapse(GO:0032280) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 5.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 2.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 8.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.5 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.1 | 1.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 20.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 1.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 1.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 3.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 5.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
0.0 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 2.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 4.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 2.1 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.1 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.0 | 5.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 4.7 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.0 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 60.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
9.6 | 115.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
8.7 | 26.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
8.4 | 25.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
7.6 | 53.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.4 | 44.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
6.5 | 19.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
5.5 | 76.3 | GO:0038132 | neuregulin binding(GO:0038132) |
5.0 | 15.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
5.0 | 50.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
4.9 | 73.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
4.9 | 14.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
4.6 | 32.3 | GO:1990254 | keratin filament binding(GO:1990254) |
4.4 | 4.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
4.3 | 12.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
4.3 | 25.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.1 | 94.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
4.1 | 57.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
4.0 | 19.8 | GO:0055100 | adiponectin binding(GO:0055100) |
3.5 | 10.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
3.5 | 10.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
3.4 | 20.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
3.2 | 38.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.0 | 9.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
2.9 | 8.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.9 | 11.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
2.8 | 13.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
2.7 | 10.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.7 | 40.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
2.7 | 10.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
2.6 | 23.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
2.6 | 23.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.6 | 33.2 | GO:0097016 | L27 domain binding(GO:0097016) |
2.5 | 17.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.5 | 12.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.5 | 47.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.5 | 10.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
2.5 | 7.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
2.4 | 4.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.4 | 7.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
2.4 | 53.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
2.4 | 9.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
2.4 | 35.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.4 | 18.8 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.3 | 9.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
2.3 | 9.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.3 | 9.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
2.3 | 18.5 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
2.3 | 25.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.2 | 17.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
2.1 | 21.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.1 | 8.6 | GO:0070052 | collagen V binding(GO:0070052) |
2.1 | 2.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 6.1 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
2.0 | 26.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.9 | 7.8 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.9 | 13.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.9 | 11.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.8 | 5.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.8 | 30.3 | GO:0005542 | folic acid binding(GO:0005542) |
1.8 | 5.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.8 | 24.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.8 | 7.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.7 | 41.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.7 | 8.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
1.7 | 15.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.7 | 28.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.7 | 6.6 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
1.6 | 4.9 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
1.6 | 1.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.5 | 62.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.5 | 10.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.5 | 221.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.5 | 9.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.5 | 6.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.5 | 64.3 | GO:0038191 | neuropilin binding(GO:0038191) |
1.5 | 6.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
1.5 | 16.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.5 | 5.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
1.5 | 16.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.5 | 8.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.4 | 5.8 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
1.4 | 5.7 | GO:0035501 | MH1 domain binding(GO:0035501) |
1.4 | 7.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.4 | 5.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.4 | 2.8 | GO:0032427 | GBD domain binding(GO:0032427) |
1.4 | 24.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.4 | 113.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.4 | 20.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.4 | 38.2 | GO:0031005 | filamin binding(GO:0031005) |
1.3 | 22.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.3 | 14.7 | GO:0045159 | myosin II binding(GO:0045159) |
1.3 | 81.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 10.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.3 | 5.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.3 | 11.4 | GO:0045545 | syndecan binding(GO:0045545) |
1.3 | 5.0 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.3 | 8.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.3 | 2.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
1.2 | 5.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.2 | 22.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.2 | 7.4 | GO:1903135 | cupric ion binding(GO:1903135) |
1.2 | 50.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.2 | 3.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
1.2 | 4.9 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
1.2 | 4.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 19.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.2 | 25.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.2 | 15.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.2 | 50.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
1.1 | 13.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 4.5 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.1 | 10.1 | GO:0043426 | MRF binding(GO:0043426) |
1.1 | 2.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
1.1 | 38.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.1 | 13.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 8.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 56.6 | GO:0042379 | chemokine receptor binding(GO:0042379) |
1.1 | 18.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.1 | 2.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.1 | 31.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.1 | 23.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.1 | 7.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.1 | 4.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.1 | 7.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.1 | 31.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.0 | 4.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.0 | 4.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 7.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.0 | 7.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
1.0 | 8.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.0 | 6.0 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
1.0 | 4.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.0 | 25.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.0 | 7.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.0 | 2.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.0 | 2.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.0 | 7.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 13.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.0 | 2.9 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
1.0 | 21.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 5.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.9 | 9.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.9 | 2.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 4.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.9 | 1.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.9 | 2.7 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.9 | 15.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.8 | 2.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 5.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.8 | 2.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.8 | 11.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 4.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.8 | 2.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.8 | 17.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 6.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 8.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 24.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.8 | 3.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 2.4 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.8 | 2.4 | GO:0001156 | RNA polymerase III transcription factor binding(GO:0001025) TFIIIC-class transcription factor binding(GO:0001156) |
0.8 | 8.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 7.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 2.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.8 | 23.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 3.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 12.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 1.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.7 | 2.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.7 | 3.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.7 | 4.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.7 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 10.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 164.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.7 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.7 | 2.8 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.7 | 16.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.7 | 4.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.7 | 11.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.7 | 29.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.7 | 13.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 4.0 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 7.9 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.7 | 9.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.7 | 3.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.7 | 3.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 38.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.6 | 10.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 10.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 2.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.6 | 6.9 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 2.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 3.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.6 | 9.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 4.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 1.8 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.6 | 16.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 3.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.6 | 7.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.8 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.6 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 2.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.6 | 7.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.6 | 3.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.6 | 2.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.6 | 12.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 3.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 8.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.6 | 4.5 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.6 | 4.0 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.6 | 2.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.6 | 5.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.6 | 2.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.6 | 14.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 7.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 3.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 4.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 16.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 8.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.5 | 3.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 2.1 | GO:0047888 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.5 | 8.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 7.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 153.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 2.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.5 | 1.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 1.5 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.5 | 12.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.5 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 3.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 3.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.5 | 5.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 42.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 12.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 2.4 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.5 | 16.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 8.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 14.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 5.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 146.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.5 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 10.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 6.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 14.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 18.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 5.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 13.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 3.8 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.4 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 6.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 2.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 4.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 5.9 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.4 | 3.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 8.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.4 | 5.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 5.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.4 | 4.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.4 | 20.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 5.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 7.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 11.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 1.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 12.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.4 | 13.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 8.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 17.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 6.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 9.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 23.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.4 | 7.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 4.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.0 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.3 | 11.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 1.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 8.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 4.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 40.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 1.7 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.3 | 8.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 3.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 1.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.3 | 4.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 37.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.3 | 3.9 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 15.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 2.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 2.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 71.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 5.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 10.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 2.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 3.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 16.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 13.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 2.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 3.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 13.8 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 0.9 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.3 | 11.2 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 5.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 9.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.3 | 1.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 6.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 2.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 2.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 3.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 1.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 0.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 1.6 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.3 | 1.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 2.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 3.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 12.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.3 | 8.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 6.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 2.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.2 | 2.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 13.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 3.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 6.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.7 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.2 | 4.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 17.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 5.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 17.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.8 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.2 | 2.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.7 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.2 | 41.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 11.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 2.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 8.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 89.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 3.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 2.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 15.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.2 | 16.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 5.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 2.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.2 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 1.0 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.2 | 2.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.0 | GO:0035258 | estrogen receptor binding(GO:0030331) steroid hormone receptor binding(GO:0035258) |
0.2 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 3.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.2 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 2.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 6.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 123.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 2.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 12.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 31.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.8 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.2 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 3.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 28.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 11.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 2.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 3.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 2.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 12.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 2.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 3.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 1.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.5 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 4.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 3.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 2.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 2.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 7.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 2.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 3.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.5 | GO:0015271 | A-type (transient outward) potassium channel activity(GO:0005250) outward rectifier potassium channel activity(GO:0015271) |
0.1 | 4.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 12.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 2.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 4.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 27.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.0 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 3.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 1.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 2.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 5.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 3.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 4.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 9.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 3.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 3.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.5 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.0 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 5.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.5 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 116.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.2 | 59.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.0 | 2.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.8 | 78.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.5 | 47.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 115.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 59.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.1 | 95.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.1 | 39.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.1 | 21.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 45.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.8 | 79.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 16.9 | PID FOXO PATHWAY | FoxO family signaling |
0.7 | 41.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.7 | 3.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 7.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 79.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 9.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 17.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 9.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 21.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 44.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 50.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 42.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 16.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 44.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 13.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 10.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 19.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 21.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 4.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 14.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 26.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 5.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 10.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 12.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 29.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 14.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 9.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 16.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 17.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 90.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 104.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 1.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 31.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 7.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 17.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 6.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 29.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 6.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 8.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 9.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 17.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 4.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 14.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 6.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 8.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 5.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 11.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 7.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 14.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 228.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.9 | 139.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
2.8 | 53.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.9 | 127.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
1.4 | 40.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.4 | 44.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.3 | 30.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 21.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 94.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.2 | 31.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 35.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.2 | 39.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.1 | 139.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.0 | 15.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 27.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 18.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 41.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.0 | 2.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 27.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 24.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.9 | 28.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 15.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.8 | 13.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 20.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 13.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 17.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 11.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 19.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 29.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 10.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 11.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 11.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.7 | 24.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 11.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 11.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 28.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 23.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 10.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 5.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 4.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 11.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 17.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 48.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 16.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 8.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 11.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 14.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 6.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 14.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 46.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 2.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 59.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 27.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 27.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 21.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 108.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 2.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 7.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 14.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 3.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 7.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 9.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 13.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 12.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 10.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 7.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 7.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 10.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 3.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 5.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 13.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 14.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 11.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 16.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 13.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 8.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 14.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 4.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 4.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 8.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 5.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 3.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 4.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 5.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 2.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 6.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 3.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 1.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 4.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 3.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 14.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 44.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 5.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 4.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 3.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 7.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.8 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 4.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 1.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |